We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTCT icon
251
PTC Therapeutics
PTCT
$6.22B
$10.9M 0.07%
273,374
UMPQ
252
DELISTED
Umpqua Holdings Corp
UMPQ
$10.8M 0.07%
562,932
-18,507
-3% -$374K
CERN
253
DELISTED
Cerner Corp
CERN
$10.7M 0.07%
115,369
+59,951
+108% +$4.56M
SWTX
254
DELISTED
SpringWorks Therapeutics
SWTX
$10.7M 0.07%
172,556
+31,722
+23% +$2.1M
ZS icon
255
Zscaler
ZS
$25.3B
$10.5M 0.07%
32,719
-4,553
-12% -$1.43M
FRC
256
DELISTED
First Republic Bank
FRC
$10.5M 0.07%
50,879
+40,711
+400% +$8.59M
DE icon
257
Deere & Co
DE
$166B
$10.5M 0.07%
30,570
-457
-1% -$159K
CPLG
258
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$10.5M 0.07%
+578,705
New +$9.13M
RDNT icon
259
RadNet
RDNT
$4.97B
$10.4M 0.07%
346,675
+10,464
+3% +$308K
NVAX icon
260
Novavax
NVAX
$1.21B
$10.4M 0.07%
72,935
-42,844
-37% -$7.36M
ZBH icon
261
Zimmer Biomet
ZBH
$18.7B
$10.3M 0.07%
83,365
+10,647
+15% +$1.39M
VRAY
262
DELISTED
ViewRay, Inc.
VRAY
$10.2M 0.07%
1,849,879
+609,987
+49% +$3.72M
KR icon
263
Kroger
KR
$36.6B
$10M 0.06%
221,958
+24,052
+12% +$1.01M
WAT icon
264
Waters Corp
WAT
$37.3B
$9.93M 0.06%
26,654
-3,171
-11% -$1.11M
ICE icon
265
Intercontinental Exchange
ICE
$87.6B
$9.57M 0.06%
70,000
+12,185
+21% +$1.61M
PH icon
266
Parker-Hannifin
PH
$120B
$9.4M 0.06%
29,537
+369
+1% +$114K
CTAS icon
267
Cintas
CTAS
$87.2B
$9.33M 0.06%
84,236
+57,400
+214% +$6.18M
HAS icon
268
Hasbro
HAS
$13.6B
$9.21M 0.06%
90,454
-3,699
-4% -$355K
TWLO icon
269
Twilio
TWLO
$29.2B
$9.15M 0.06%
34,761
-827
-2% -$247K
NEO icon
270
NeoGenomics
NEO
$2.01B
$9.15M 0.06%
268,194
+8,074
+3% +$316K
BLK icon
271
Blackrock
BLK
$170B
$9.01M 0.06%
9,840
-1,447
-13% -$1.32M
WAB icon
272
Wabtec
WAB
$49.8B
$9M 0.06%
97,708
+4,434
+5% +$407K
MCFE
273
DELISTED
McAfee Corp. Class A Common Stock
MCFE
$8.97M 0.06%
+347,651
New +$8.38M
USB icon
274
US Bancorp
USB
$98.5B
$8.94M 0.06%
76,021
-8,721
-10% -$516K
EPIX
275
DELISTED
ESSA Pharma
EPIX
$8.89M 0.06%
626,276
+325,751
+108% +$3.63M

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.